<DOC>
	<DOCNO>NCT00320606</DOCNO>
	<brief_summary>Antirejection medicine , also know immunosuppressive drug , prescribe organ transplant recipient prevent body reject new organ . Long-term use drug place transplant recipients high risk serious infection certain type cancer . The purpose study determine whether immunosuppressive drug safely withdraw minimum 9 month child receive liver transplant least 4 year ago .</brief_summary>
	<brief_title>Withdrawal Immunosuppression Pediatric Liver Transplant Recipients</brief_title>
	<detailed_description>In order prevent rejection transplant organ , transplant recipient prescribe strict , lifelong regimen immunosuppressive drug . While drug help prevent body reject transplant , carry numerous complication , include increase risk serious infection certain type cancer . However , mount evidence significant percentage liver transplant recipient maintain healthy , function transplant without ongoing immunosuppression . This study determine whether gradual withdrawal eventual discontinuation immunosuppressive medication safely accomplished child receive liver transplant parent . Twenty eligible patient 18 year old time transplant , whose donor parent , receive transplant least four year ago enrol study . Liver recipients initial screen assessment consist medical history , liver biopsy , urine blood collection . Eligible recipient place modified medication schedule gradually decrease immunosuppression medication slowly 9- 12-month period , time closely monitor study staff . Immunosuppressive drug provide study . For minimum 3 maximum 7 year , monthly telephone consultation quarterly study visit occur . Visits include physical exam blood collection monitor child 's health withdrawal phase . The exact schedule immunosuppressant withdrawal determine study physician base participant 's health immune function test result . Donor nondonor parent ask provide one blood sample initial study visit immunologic genetic testing . *** IMPORTANT NOTICE : *** The National Institute Allergy Infectious Diseases Immune Tolerance Network recommend discontinuation immunosuppressive therapy recipient cell , organ , tissue transplant outside physician-directed , control clinical study . Discontinuation prescribe immunosuppressive therapy result serious health consequence perform certain rare circumstance , upon recommendation guidance health care provider .</detailed_description>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>Inclusion Criteria Liver Recipients : Received liver live parent donor Received transplant least 4 year prior study entry Less 18 year age time transplant Parent guardian willing provide inform consent Inclusion Criteria Liver Donors : Willing participate study Exclusion Criteria Liver Recipients : Underwent transplant liver failure relate autoimmune disease Underwent transplant second organ simultaneously liver transplant OR liver retransplantation Receiving immunosuppression one drug 50 % increase dose current immunosuppressive drug HIV infection Hepatitis B C virus infection Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>allograft function</keyword>
	<keyword>anti-rejection</keyword>
	<keyword>immunosuppression withdrawal</keyword>
	<keyword>liver transplant</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>live donor transplant</keyword>
</DOC>